Critical Care System Helps Monitor Urine Flow
By HospiMedica International staff writers Posted on 12 Aug 2019 |

Image: A new urine flow monitor protects against kidney injury (Photo courtesy of RenalSense).
A novel diagnostics system provides real-time monitoring of urine flow in critical care and peri-operative settings.
The RenalSense (Jerusalem, Israel) Clarity RMS system is an innovative system designed to continuously monitor urine flow. The system uses sophisticated sensor technology and proprietary algorithms in order to measure non-homogeneous, time-varying liquids, even in unstable, uncontrolled environments, automatically transmitting real-time data to medical staff on a 24/7 basis. The approach, which involves complex numeric techniques, is based on an in-depth understanding of fluid dynamics, thermodynamics, human physiology, and target environment properties.
The patented sensor measures, analyzes, and interprets the continuously changing composition and flow volume of urine, generating a unique set of electronic signals that represent ongoing changes in renal function. Proprietary algorithms separate the “noise” from these signals with high sensitivity and stability, achieving clear recognition and correct interpretation of different processes in the extremely dynamic environment. Timely alerts of fluctuations provide an early warning sign of acute kidney injury (AKI) risk, facilitating rapid intervention.
“We've known for years that urine output information is essential for management of critical care patients. The time has come for urine output to be monitored electronically in real-time, as is the standard practice for other vital signs in the ICU,” said Professor John Kellum, MD, of the University of Pittsburgh Medical Center (UPMC, PA, USA).
AKI is common among intensive care unit (ICU) patients, with a broad spectrum of clinical presentations ranging from mild to severe injury that may result in permanent and complete loss of renal function and high mortality. The underlying mechanisms of AKI include a decrease in the kidney's ability to excrete nitrogenous waste, manage electrolytes, regulate intravascular volume, and assist with maintenance of the acid-base status via urine excretion.
Related Links:
RenalSense
University of Pittsburgh Medical Center
The RenalSense (Jerusalem, Israel) Clarity RMS system is an innovative system designed to continuously monitor urine flow. The system uses sophisticated sensor technology and proprietary algorithms in order to measure non-homogeneous, time-varying liquids, even in unstable, uncontrolled environments, automatically transmitting real-time data to medical staff on a 24/7 basis. The approach, which involves complex numeric techniques, is based on an in-depth understanding of fluid dynamics, thermodynamics, human physiology, and target environment properties.
The patented sensor measures, analyzes, and interprets the continuously changing composition and flow volume of urine, generating a unique set of electronic signals that represent ongoing changes in renal function. Proprietary algorithms separate the “noise” from these signals with high sensitivity and stability, achieving clear recognition and correct interpretation of different processes in the extremely dynamic environment. Timely alerts of fluctuations provide an early warning sign of acute kidney injury (AKI) risk, facilitating rapid intervention.
“We've known for years that urine output information is essential for management of critical care patients. The time has come for urine output to be monitored electronically in real-time, as is the standard practice for other vital signs in the ICU,” said Professor John Kellum, MD, of the University of Pittsburgh Medical Center (UPMC, PA, USA).
AKI is common among intensive care unit (ICU) patients, with a broad spectrum of clinical presentations ranging from mild to severe injury that may result in permanent and complete loss of renal function and high mortality. The underlying mechanisms of AKI include a decrease in the kidney's ability to excrete nitrogenous waste, manage electrolytes, regulate intravascular volume, and assist with maintenance of the acid-base status via urine excretion.
Related Links:
RenalSense
University of Pittsburgh Medical Center
Latest Critical Care News
- Discovery of Heart’s Hidden Geometry to Revolutionize ECG Interpretation
- New Approach Improves Diagnostic Accuracy for Esophageal Motility Disorders
- Wristband Sensor Provides All-In-One Monitoring for Diabetes and Cardiovascular Care
- Handheld Device Enables Imaging and Treatment of Oral Cancer in Low-Resource Settings
- New Fully Automated AI Algorithm More Effective at Predicting Heart Attack Risk
- First-In-Kind Self-Assembling Collagen Scaffold Advances Wound Care
- AI-Enhanced Echocardiography Improves Early Detection of Amyloid Buildup in Heart
- Consumer Wearables Could Predict Pediatric Surgery Complications
- Wireless Implant Delivers Chemotherapy Deep into Tumors Without Side Effects
- Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
Channels
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more